โš ๏ธ Research Use Only. Not for human use or medical advice.
Metabolic (GLP-1)

Semaglutide

GLP-1 receptor agonist (the molecule in Ozempic and Wegovy)
Class
GLP-1 agonist
Mol. Weight
~4114 Da
Half-Life
~7 days
Storage
-20 C lyophilised
Reconstitution
BAC water
Frequency
Once weekly

๐Ÿ”ฌ Overview

Semaglutide is a GLP-1 receptor agonist and one of the most widely studied incretin compounds. As a prescription medicine it is marketed under brand names for type 2 diabetes and weight management. Sold as a research chemical it is lyophilised powder for reconstitution.

It is dosed once weekly because of its long half-life. Researchers often compare it with the dual agonist tirzepatide and the triple agonist retatrutide.

๐Ÿ’‰ Research-Reported Dosing

ProtocolDoseFrequencyNotes
Research start0.25 mgOnce weeklyFirst 4 weeks, tolerance building
Step 20.5 mgOnce weeklyAfter 4 weeks
Step 31.0 mgOnce weeklyFurther titration
Upper range1.7-2.4 mgOnce weeklySlow escalation only

Figures are drawn from research literature and community protocols. They are not dosing recommendations. Use the dosage calculator to convert any amount into a syringe volume.

โš—๏ธ Reconstitution & Solubility

  1. Bring vial and bacteriostatic water to room temperature
  2. Swab stoppers with alcohol and let dry
  3. Add bacteriostatic water slowly down the vial wall
  4. Swirl gently until fully clear, never shake
  5. Refrigerate at 2 to 8 C after reconstitution
Solubility: semaglutide is soluble in bacteriostatic water and reconstitutes to a clear solution. No additional solvent is required.

๐Ÿ“ Administration

Subcutaneous injection once weekly in research settings. Slow titration is the norm to limit gastrointestinal effects. Use the calculator to turn a weekly milligram dose into units on an insulin syringe.

๐Ÿ“š Research Notes

Extensive clinical literature exists for the approved drug. The most common reported effects are gastrointestinal (nausea, reduced appetite), generally strongest at the start of a dose step and easing with time.

โš ๏ธ Safety & Disclaimer

Semaglutide is a prescription-only medicine. Research-chemical powder is not a substitute for prescribed, pharmacy-grade product and is not for human use. Known risks include gastrointestinal effects, gallbladder problems, pancreatitis signals, and a class boxed warning about thyroid C-cell tumours. Not medical advice. Human use should only occur under a doctor.